Benign prostatic hypertrophy
Adrenogenital disorder
Butorphanol, Urine
Albumin Creatinine Ratio
Bilirubin, Direct, Serum
Coagulation Factor VIII Activity Assay, Plasma
5-Hydroxyindoleacetic Acid (5-HIAA), 24 Hour, Urine
Parainfluenza Virus (Types 1, 2, 3) Antibodies
Levetiracetam, Serum
Gabapentin, Urine
LDS
Sign up
Log in
LDS
/
Medical Tests
/
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
All
Diseases
Overview
Clinical Utility
Interpretation
Reference Ranges
Methodology
Specimen Collection
Additional Testing
Turnaround Time
CPT
LOINC
ICD10
Additional ICD10
References
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
Medical Test
References
Access to
ABL1 Kinase Domain Mutation Analysis for Tyrosine Kinase Inhibitor Resistance in CML, NGS
is restricted.
Sign up now